Source - RNS
RNS Number : 2387J
British American Tobacco PLC
16 August 2019
 

British American Tobacco p.l.c. (the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Holly Keller Koeppel

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

British American Tobacco p.l.c.

b)

LEI

213800FKA5MF17RJKT63

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 




Identification code

Deferred Stock Units ("DSUs") tracking the value of British American Tobacco p.l.c. American Depositary Shares ("ADSs") in accordance with the terms of the Reynolds American Inc. ("RAI") Amended and Restated Deferred Compensation Plan.

N/A because the transaction relates to financial instruments linked to the issuer's ADSs

b)

Nature of the transaction

Credit of additional DSUs by reference to the value of dividends declared on the ADSs underlying the DSUs.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

$Nil

375.35

d)

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

375.35

 

 

$Nil

e)

Date of the transaction

2019-08-13

f)

Place of the transaction

Outside a trading venue

 

 

Name of officer of issuer responsible for making notification: Bridget Creegan

Date of notification: 16 August 2019

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHZELFFKVFEBBE